Food Safety Incidents

Products offered as being slimming has been detected in Dietary supplement ozemzinh the.

Written by SGS Digicomply Editorial Team | Feb 27, 2026 11:00:00 PM

Food Safety Incident Report

Date: February 12, 2026

A recent incident has been reported involving a dietary supplement that has been marketed for its slimming properties. The Brazilian Health Regulatory Agency (ANVISA) has detected issues with this product, which raises significant concerns regarding food safety and consumer health.

The dietary supplement in question has been linked to potential hazards that may pose risks to individuals who consume it. Such supplements often promise weight loss benefits but can contain ingredients that are not adequately tested for safety or efficacy. This incident highlights the importance of regulatory oversight in the dietary supplement industry to ensure that products are safe for public consumption.

Consumers are advised to exercise caution when considering dietary supplements, particularly those that claim to promote weight loss. It is essential to consult healthcare professionals before starting any new supplement regimen, especially if the product has been flagged by health authorities.

As this situation develops, further investigations will be conducted to assess the safety of the dietary supplement and to determine the appropriate actions needed to protect public health. The regulatory agency will continue to monitor the situation and provide updates as necessary.

For more information on dietary supplements and food safety, individuals are encouraged to refer to official health guidelines and resources.

  • Incident: Products offered as being slimming has been detected in Dietary supplement ozemzinh the.
  • Date: 2026-02-12
  • Product: Dietary supplement ozemzinh the
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Brazil
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Source: Brazilian Health Regulatory Agency - ANVISA